Efficacy of Auricular Acupuncture Therapy in the Prevention of CIPN in Breast Cancer
Recruiting · NCT07092111 · Interventional (participants receive a specific treatment) · Lead sponsor: The First Affiliated Hospital with Nanjing Medical University
View the official record on ClinicalTrials.gov →Interventions studied
Auricular acupuncture treatmentSham acupuncture group
What this trial is about
Evaluate the Efficacy of Auricular Acupuncture Therapy via the Seirin Pyonex Needles in the Prevention of Chemotherapy-Induced Peripheral Neuropathy in Breast Cancer
Who can take part
Age range
18 Years to 75 Years
Sex
Female
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Patients with breast cancer diagnosed with stage I-III;
- Planned to receive 4 cycles of taxane chemotherapy and have not taken neurostable drugs within three months;
- 18 years old≤ age≤ 75 years old, female;
- Subjects voluntarily participate in this trial and sign the informed consent form.
Exclusion criteria
- Patients who have had acupuncture treatment in the past;
- After examination by a doctor, there is a local infection at or near the acupuncture site, which is not suitable for acupuncture.
- Platelets\< 50,000/μL;
- Patients with CIPN≥1 grade 1 (NCI-CTCAE);
- Peripheral neuropathy or other neuropathic pain caused by diabetes mellitus or other factors related to HIV infection.
Where it is running
1 location listed.
- Jiangsu Provincial People's Hospital - Nanjing, Jiangsu, China